Evidence map›Paper›PMID 28935153›Full record

ArticleProgress in biophysics and molecular biology2017

Load-dependent effects of apelin on murine cardiomyocytes.

Rémi Peyronnet, Christian Bollensdorff, Rebecca A Capel, Eva A Rog-Zielinska, Christopher E Woods, David N Charo, Oleg Lookin, Giovanni Fajardo, Michael Ho, Thomas Quertermous and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Progress in biophysics and molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Apelin as a Potential Regulator of Peak Athletic Performance.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Rémi PeyronnetInstitute for Experimental Cardiovascular Medicine, University Heart Centre Freiburg · Bad Krozingen, Medical School of the University of Freiburg, Germany; Imperial College London, NHLI, Heart Science Centre, UK. Electronic address: remi.peyronnet@universitaets-herzzentrum.de.
Christian BollensdorffImperial College London, NHLI, Heart Science Centre, UK; Sidra Medical and Research Center, Qatar Foundation, Qatar.
Rebecca A CapelDepartment of Pharmacology, University of Oxford, UK.
Eva A Rog-ZielinskaInstitute for Experimental Cardiovascular Medicine, University Heart Centre Freiburg · Bad Krozingen, Medical School of the University of Freiburg, Germany; Imperial College London, NHLI, Heart Science Centre, UK.
Christopher E WoodsStanford University Division of Cardiovascular Medicine, Stanford, USA; Palo Alto Medical Foundation, Burlingame, CA, USA.
David N CharoStanford University Division of Cardiovascular Medicine, Stanford, USA.
Oleg LookinUral Branch of the Russian Academy of Sciences, Ekaterinburg, Russian Federation.
Giovanni FajardoStanford University Division of Cardiovascular Medicine, Stanford, USA.
Michael HoStanford University Division of Cardiovascular Medicine, Stanford, USA.
Thomas QuertermousStanford University Division of Cardiovascular Medicine, Stanford, USA.
Euan A AshleyStanford University Division of Cardiovascular Medicine, Stanford, USA.
Peter KohlInstitute for Experimental Cardiovascular Medicine, University Heart Centre Freiburg · Bad Krozingen, Medical School of the University of Freiburg, Germany; Imperial College London, NHLI, Heart Science Centre, UK.
Stanford Medicine · USUniversity of Freiburg · DEBritish Heart Foundation · GBUniversity of Oxford · GBUral Branch of the Russian Academy of Sciences · RU

Funding

British Heart Foundation FS/12/17/29532British Heart Foundation FS/15/3/31047European Research Council 323009
6 · The paper itself

Abstract

The apelin peptide is described as one of the most potent inotropic agents, produced endogenously in a wide range of cells, including cardiomyocytes. Despite positive effects on cardiac contractility in multicellular preparations, as well as indications of cardio-protective actions in several diseases, its effects and mechanisms of action at the cellular level are incompletely understood. Here, we report apelin effects on dynamic mechanical characteristics of single ventricular cardiomyocytes, isolated from mouse models (control, apelin-deficient [Apelin-KO], apelin-receptor KO mouse [APJ-KO]), and rat. Dynamic changes in maximal velocity of cell shortening and relaxation were monitored. In addition, more traditional indicators of inotropic effects, such as maximum shortening (in mechanically unloaded cells) or peak force development (in auxotonic contracting cells, preloaded using the carbon fibre technique) were studied. The key finding is that, using Apelin-KO cardiomyocytes exposed to different preloads with the 2-carbon fibre technique, we observe a lowering of the slope of the end-diastolic stress-length relation in response to 10 nM apelin, an effect that is preload-dependent. This suggests a positive lusitropic effect of apelin, which could explain earlier counter-intuitive findings on an apelin-induced increase in contractility occurring without matching rise in oxygen consumption.

Indexed as

Mechanical PhenomenaAnimalsApelinBiomechanical PhenomenaGene Knockout TechniquesMiceMyocytes, CardiacRatsApelinCarbon fibresContractilityFrank-Starling GainLusitropyStretch

Identifiers

PMID28935153
PMCPMC5726609
OpenAlexW2756104676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.